IBER

Ibere Pharmaceuticals
IBER

Overview Fund Activity
Delisted

IBER was delisted on the 1st of March, 2023.

Back to rankings

32 hedge funds and large institutions have $61.2M invested in Ibere Pharmaceuticals in 2021 Q2 according to their latest regulatory filings, with 32 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
32
Holders Change
+32
Holders Change %
–
% of All Funds
0.56%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
32
Increased
–
Reduced
–
Closed
–
Calls
$74K
Puts
–
Net Calls
+$74K
Net Calls Change
+$74K

Top Buyers

1
Hudson Bay Capital Management
Hudson Bay Capital Management
Connecticut
$6.01M
2
Citadel Advisors
Citadel Advisors
Florida
$5.32M
3
PAMP
Polar Asset Management Partners
Ontario, Canada
$4.84M
4
LA
Linden Advisors
New York
$4.35M
5
Marshall Wace
Marshall Wace
United Kingdom
$4.35M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Shares
Change %
BCM
26
Basso Capital Management
Connecticut
$293K +$293K +30,295 New
PC
27
Periscope Capital
Ontario, Canada
$290K +$290K +30,000 New
D.E. Shaw & Co
28
D.E. Shaw & Co
New York
$242K +$242K +25,000 New
Capstone Investment Advisors
29
Capstone Investment Advisors
New York
$242K +$242K +25,000 New
GCL
30
Glazer Capital LLC
New York
$107K +$107K +11,085 New
PCM
31
Prelude Capital Management
New York
$97K +$97K +10,000 New
AA
32
Ancora Advisors
Ohio
$7K +$7K +700 New
1
2